NM_015192.4:c.3116T>C
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_015192.4(PLCB1):āc.3116T>Cā(p.Ile1039Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000494 in 1,612,872 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_015192.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00235 AC: 357AN: 152234Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000726 AC: 181AN: 249230Hom.: 0 AF XY: 0.000543 AC XY: 73AN XY: 134536
GnomAD4 exome AF: 0.000301 AC: 439AN: 1460520Hom.: 3 Cov.: 31 AF XY: 0.000281 AC XY: 204AN XY: 726366
GnomAD4 genome AF: 0.00234 AC: 357AN: 152352Hom.: 1 Cov.: 33 AF XY: 0.00212 AC XY: 158AN XY: 74500
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
PLCB1: BS1:Supporting -
- -
Developmental and epileptic encephalopathy, 12 Benign:2
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
- -
not specified Benign:1
- -
Inborn genetic diseases Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at